Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2020;10(2): 150-165. doi: 10.34172/apb.2020.021
PMID: 32373485        PMCID: PMC7191226

Review Article

Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery

Iti Chauhan 1 * ORCID, Mohd Yasir 2, Madhu Verma 1, Alok Pratap Singh 1

Cited by CrossRef: 253

1- Patil T, Gujarathi N, Aher A, Pachpande H, Sharma C, Ojha S, Goyal S, Agrawal Y. Recent Advancements in Topical Anti-Psoriatic Nanostructured Lipid Carrier-Based Drug Delivery. IJMS. 2023;24(3):2978 [Crossref]
2- Khater D, Nsairat H, Odeh F, Saleh M, Jaber A, Alshaer W, Al Bawab A, Mubarak M. Design, Preparation, and Characterization of Effective Dermal and Transdermal Lipid Nanoparticles: A Review. Cosmetics. 2021;8(2):39 [Crossref]
3- Yadav S, Mishra M. Nanocrystals in Drug Delivery: A Cutting-Edge Approach for Enhanced Therapeutic Values. CNANOM. 2025;15(5):492 [Crossref]
4- Atapour-Mashhad H, Tayarani-Najaran Z, Golmohammadzadeh S. Preparation and characterization of novel nanostructured lipid carriers (NLC) and solid lipid nanoparticles (SLN) containing coenzyme Q10 as potent antioxidants and antityrosinase agents. Heliyon. 2024;10(11):e31429 [Crossref]
5- Han W, Liu F, Muhammad M, Liu G, Li H, Xu Y, Sun S. Application of biomacromolecule-based passive penetration enhancement technique in superficial tumor therapy: A review. International Journal of Biological Macromolecules. 2024;272:132745 [Crossref]
6- Hosseini S, Khorsand Zak A, Nikravesh A, Oroojalian F. Simultaneous co-delivery of a reporter EGFP gene and doxorubicin to HepG2 cells using AuNPs-Functionalized Graphene Oxide Nanostructures. Nanomedicine. 2026;21(1):27 [Crossref]
7- Ali Z, Din F, Zahid F, Sohail S, Imran B, Khan S, Malik M, Zeb A, Khan G. RETRACTED ARTICLE: Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout. BMC Pharmacol Toxicol. 2022;23(1) [Crossref]
8- Vasu M, Yadav P, Satyanarayana Y, Ahlawat J, Sandeep D, Kumar K. Golden Threads of Lipid Nanoparticles (LNPs) contributing to COVID-19 mRNA Vaccine: A Review. BioNanoSci. 2024;14(3):3430 [Crossref]
9- Dabhadkar M, Kulkarni M. Novel drug delivery systems in topical treatment of atopic dermatitis. Naunyn-Schmiedeberg's Arch Pharmacol. 2025;398(8):9851 [Crossref]
10- Burdușel A, Andronescu E. Lipid Nanoparticles and Liposomes for Bone Diseases Treatment. Biomedicines. 2022;10(12):3158 [Crossref]
11- Geremamo Y, Hasan A, Razzak S, Uddin S. Unlocking the potential of lipid-based nanoparticles for intranasal drug delivery in Parkinson’s disease. International Journal of Pharmaceutics. 2026;692:126604 [Crossref]
12- Oussou R, La Camera S, Marivingt‐Mounir C, Chollet J. Salicylic acid: a key natural foundation for next‐generation plant defense stimulators. Pest Management Science. 2026;82(3):2165 [Crossref]
13- Saini K, Modgill N, Singh K, Kakkar V. Tetrahydrocurcumin Lipid Nanoparticle Based Gel Promotes Penetration into Deeper Skin Layers and Alleviates Atopic Dermatitis in 2,4-Dinitrochlorobenzene (DNCB) Mouse Model. Nanomaterials. 2022;12(4):636 [Crossref]
14- Susa F, Arpicco S, Pirri C, Limongi T. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery. Pharmaceutics. 2024;16(7):849 [Crossref]
15- Sitinjak F, Aisyah N, Aulifa D, Budiman A. Advancements in nanotechnology for sunscreens: Preparation, characterization, and mechanisms of UV protection. OpenNano. 2025;26:100259 [Crossref]
16- Sarma K, Akther M, Ahmad I, Afzal O, Altamimi A, Alossaimi M, Jaremko M, Emwas A, Gautam P. Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer. Molecules. 2024;29(5):1076 [Crossref]
17- Dighe S, Lonkar S, Jog S, Mangrulkar S, Sawarkar S. Thermosensitive in-situ gel of Nifedipine: A strategy to offset cognition impairment in Alzheimer's disease. Journal of Drug Delivery Science and Technology. 2024;102:106393 [Crossref]
18- Liu W, Hsieh Y, Ko H, Wu Y. Formulation Approaches to Crystalline Status Modification for Carotenoids: Impacts on Dissolution, Stability, Bioavailability, and Bioactivities. Pharmaceutics. 2023;15(2):485 [Crossref]
19- Ghasemiyeh P, Mohammadi-Samani S, Noorizadeh K, Zadmehr O, Rasekh S, Mohammadi-Samani S, Dehghan D. Novel topical drug delivery systems in acne management: Molecular mechanisms and role of targeted delivery systems for better therapeutic outcomes. Journal of Drug Delivery Science and Technology. 2022;74:103595 [Crossref]
20- Sahoo L, Jena G, Patro C, Patro C, Meher N. In Vitro and In Vivo Characterization of Transdermal Patch Loaded with Nanostructured Lipid Carrier for Bioavailability Enhancement of Dolutegravir Sodium Using Taguchi and Box-Behnken Design. BioNanoSci. 2023;13(3):1213 [Crossref]
21- Dludla S, Mashabela L, Ng’andwe B, Makoni P, Witika B. Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives. Polymers. 2022;14(17):3580 [Crossref]
22- Hashmi A, Zahra F, Ravi R, Sekar M. Engineering thiolated polyethoxylated surfactants for mucoadhesive and biointeractive lipid-based drug delivery systems: Molecular design, performance, and translational potential. Colloids and Surfaces B: Biointerfaces. 2026;263:115563 [Crossref]
23- Breheny C, Colbert D, Bezerra G, Geever J, Geever L. Evaluating the Chemical Resistance and Performance of Thermochromic Polymers for Food Packaging. Materials. 2025;18(9):2085 [Crossref]
24- Boyuklieva R, Pilicheva B. Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders. Biomedicines. 2022;10(7):1706 [Crossref]
25- Rajendran A, Vadakkepushpakath A. Natural Food Components as Biocompatible Carriers: A Novel Approach to Glioblastoma Drug Delivery. Foods. 2024;13(17):2812 [Crossref]
26- Chandpa H, Gupta A, Naskar S, Meena J. Nanoparticles engineering strategies for lymph-node targeted cancer immunotherapy. Nano Trends. 2025;11:100128 [Crossref]
27- Almukadi H, Eid B, Shaik R, Abdel-Naim A, Esmat A. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects. Biomedicine & Pharmacotherapy. 2021;143:112199 [Crossref]
28- Chakraborty N, Narayanan V, Gautam H. Nano-Therapeutics to Treat Acne Vulgaris. Indian J Microbiol. 2022;62(2):167 [Crossref]
29- Alamri A, Ishrat G, Zahid F, Ali Z, Alqahtani A, Lahiq A, Alsharif S, Sahab M, Din F. Development and evaluation of the rivaroxaban loaded nanostructured lipid carriers for improved oral bioavailability and safety. Sci Rep. 2025;15(1) [Crossref]
30- Amer R, Yassin G, Mohamed R, Fayez A. Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats. AAPS PharmSciTech. 2021;22(5) [Crossref]
31- Zhang Y, Yang N, Xie L, Shu F, Shi Q, Shaheen N. A New 3D Cultured Liver Chip and Real-Time Monitoring System Based on Microfluidic Technology. Micromachines. 2020;11(12):1118 [Crossref]
32- Hasanpour F, Budai-Szűcs M, Kovács A, Ambrus R, Jójárt-Laczkovich O, Cseh M, Geretovszky Z, Ayaydin F, Berkó S. Improvement of lidocaine skin permeation by using passive and active enhancer methods. International Journal of Pharmaceutics. 2024;660:124377 [Crossref]
33- Panda S, Afzal O, Altamimi A, Beg S. Simultaneous estimation of neratinib and naringenin from pharmaceuticals using a stability-indicating liquid chromatographic method: Application to analytical quality by design concept and multi-tool method greenness assessment. Microchemical Journal. 2023;191:108848 [Crossref]
34- Pintea A, Manea A, Pintea C, Vlad R, Bîrsan M, Antonoaea P, Rédai E, Ciurba A. Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review. Biomolecules. 2025;15(1):88 [Crossref]
35- Nsairat H, Khater D, Odeh F, Al-Adaileh F, Al-Taher S, Jaber A, Alshaer W, Al Bawab A, Mubarak M. Lipid nanostructures for targeting brain cancer. Heliyon. 2021;7(9):e07994 [Crossref]
36- Kumari P, Dang S. Dual drug loaded nanostructured lipid carrier for cytotoxic effect against breast cancer - a drug repurposing approach. Surfaces and Interfaces. 2023;40:103138 [Crossref]
37- Subroto E, Andoyo R, Indiarto R. Solid Lipid Nanoparticles: Review of the Current Research on Encapsulation and Delivery Systems for Active and Antioxidant Compounds. Antioxidants. 2023;12(3):633 [Crossref]
38- Wathoni N, Suhandi C, Elamin K, Lesmana R, Hasan N, Mohammed A, El-Rayyes A, Wilar G. Advancements and Challenges of Nanostructured Lipid Carriers for Wound Healing Applications. IJN. 2024;Volume 19:8091 [Crossref]
39- Kumar P, Ashawat M, Pandit V, Singh Verma C, Ankalgi A, Kumar M. Recent Trends in Nanocarriers for the Management of Atopic Dermatitis. PNT. 2023;11(5):397 [Crossref]
40- Mohanty D, Alsaidan O, Zafar A, Dodle T, Gupta J, Yasir M, Mohanty A, Khalid M. Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation. Pharmaceutics. 2023;15(7):1985 [Crossref]
41- Tamma M, Nsairat H, El-Tanani M, Madi R. In vitro evaluation of lipidic nanocarriers for mebendazole delivery to improve anticancer activity . Drug Development and Industrial Pharmacy. 2024;50(11):917 [Crossref]
42- Kumar S, Garg N, Jain A, Khopade A, Pandey P, Sawant K. Nanocarriers mediated delivery of methotrexate is instrumental in treating auto-immune diseases and cancer. Journal of Drug Delivery Science and Technology. 2023;88:104969 [Crossref]
43- Molla A. Engineering Lipid Nanoparticles for Enhanced Drug Encapsulation and Release: Current Status and Future Prospective . AJPST. 2025;11(2):15 [Crossref]
44- Gondal S, Nisar U, Razzaq S, Mudassir J, Hussain A, Rahdar A, Pandey S. Nano-enabled topical therapeutics: unlocking skin-specific drug delivery. Biosci Nanotechnol. 2026;2(1) [Crossref]
45- Prajapati P, Patel K, Shah P, Surana V, Haque A, Kalam M, Shah S. An Eco‐Friendly and Sensitive Microwave‐Aided Spectrofluorophotometric Characterization of Mirabegron‐Loaded Nanocarriers by Amalgamation of Design of Experiments and White Analytical Chemistry. Luminescence. 2024;39(12) [Crossref]
46- Deshmukh R, Prajapati M, Harwansh R. Recent advances and prospects in naringin nanocarrier drug delivery system for cancer management. Journal of Drug Delivery Science and Technology. 2024;91:105182 [Crossref]
47- Thanur J, Hartanu A, Gandawiguna V. Nanostructured Lipid Carriers with the Eichhornia crassipes Extract as a Receptor, ErB-2 Inhibitor in Breast Cancer: An in Silico Study. Bioinform Biomed Res J . 2024;7(1):1 [Crossref]
48- Mohtar N, Parumasivam T, Gazzali A, Tan C, Tan M, Othman R, Fazalul Rahiman S, Wahab H. Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment. Cancers. 2021;13(14):3539 [Crossref]
49- Maiti B, Bhattacharya S. Liposomal nanoparticles based on steroids and isoprenoids for nonviral gene delivery. WIREs Nanomed Nanobiotechnol. 2022;14(1) [Crossref]
50- Mahor A, Singh P, Gupta R, Bhardwaj P, Rathore P, Kishore A, Goyal R, Sharma N, Verma J, Rosenholm J, Bansal K, Jan N. Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route. Journal of Nanotechnology. 2023;2023:1 [Crossref]
51- Emencheta S, Onugwu A, Kalu C, Ezinkwo P, Eze O, Vila M, Balcão V, Attama A, Onuigbo E. Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects. Mater Adv. 2024;5(3):986 [Crossref]
52- Pandey P, Nautiyal G, Purohit D, Lata S, Kumar V, Makhija M, Manchanda D, Minocha N, Kumar S, Kaushik D. Role of Nanoformulations in the Treatment of Lung Cancer. NANOTEC. 2025;19(3):407 [Crossref]
53- Pavaloiu R, Neagu G, Albulescu A, Deaconu M, Petrica A, Bubueanu C, Sha’at F. Development and Characterization of Topical Gels Containing Lipid Nanosystems Loaded with Echinacea purpurea. Gels. 2025;11(10):801 [Crossref]
54- Mandal P, Akhtar J, Ahmad M, Ahmad B, Khan M, Sufiyan M, Moin B, Singh A, Islam A, Ahmad A. Natural Bioactives and their Nano-formulations for Management of Acne Vulgaris: A Comprehensive Review. NPJ. 2025;15(9) [Crossref]
55- Cimino C, Leotta C, Marrazzo A, Musumeci T, Pitari G, Pignatello R, Bonaccorso A, Amata E, Barbaraci C, Carbone C. Nanostructured lipid carrier for the ophthalmic delivery of haloperidol metabolite II valproate ester (±)-MRJF22: A potential strategy in the treatment of uveal melanoma. Journal of Drug Delivery Science and Technology. 2023;87:104811 [Crossref]
56- Grewal S, Tiwary N, Malik G, Garg M, Deswal G, Chopra B, Grewal A, Dhingra A, Guarve K. Decoding Therapeutic Applications of Quercetin: Recent Advancements in Nanotechnological Strategies. PNT. 2025;13(4):596 [Crossref]
57- Kalave S, Chatterjee B, Shah P, Misra A. Transdermal Delivery of Macromolecules Using Nano Lipid Carriers. CPD. 2021;27(42):4330 [Crossref]
58- Rurarz B, Bukowczyk M, Gibka N, Piastowska-Ciesielska A, Karczmarczyk U, Ulański P. Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor. IJMS. 2023;24(4):3455 [Crossref]
59- Irannejadrankouhi S, Mivehchi H, Eskandari-Yaghbastlo A, Nejati S, Emrahoglu S, Nazarian M, Zahedi F, Madani S, Nabi-Afjadi M. Innovative nanoparticle strategies for treating oral cancers. Med Oncol. 2025;42(6) [Crossref]
60- Mohan N, Nair R, Narayanasamy D. Nanoparticle‐Integrated Transdermal Patches: A Platform for Next‐Generation Drug Delivery. Drug Development Research. 2025;86(7) [Crossref]
61- B, Goudanavar P. Advancing topical drug delivery: NLC innovations in dermatological therepeutics. Nano Trends. 2025;10:100108 [Crossref]
62- Salathia S, Gigliobianco M, Casadidio C, Di Martino P, Censi R. Hyaluronic Acid-Based Nanosystems for CD44 Mediated Anti-Inflammatory and Antinociceptive Activity. IJMS. 2023;24(8):7286 [Crossref]
63- Moghimipour E, Khazali M, MakhmalZadeh B, Abedini Baghbadorani M, Zangeneh A, Sohrabi S, Nejaddehbashi F, Hajipour F, Handali S. Development of propranolol loaded SLN for transdermal delivery: in-vitro characterization and skin deposition studies . Therapeutic Delivery. 2025;16(3):205 [Crossref]
64- Lazov C, Yoncheva K, Slavkova M. The Significance of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) in the Treatment of Atopic Dermatitis. Sci Pharm. 2026;94(1):19 [Crossref]
65- Ghobashy M, Alkhursani S, Alqahtani H, El-damhougy T, Madani M. Gold nanoparticles in microelectronics advancements and biomedical applications. Materials Science and Engineering: B. 2024;301:117191 [Crossref]
66- Makkar S, Sharma A, Rathore C, Joshi G, Rawat S. Recent Update on Applications of Nanostructured Lipid Carriers and Solid Lipid Nanocarriers in Drug Delivery Systems: A Narrative Review. CNANOM. 2025;15(5):503 [Crossref]
67- Kebede L, Masoomi Dezfooli S, Seyfoddin A. Medicinal cannabis pharmacokinetics and potential methods of delivery. Pharmaceutical Development and Technology. 2022;27(2):202 [Crossref]
68- Bonaccorso A, Cimino C, Manno D, Tomasello B, Serra A, Musumeci T, Puglisi G, Pignatello R, Carbone C. Essential Oil-Loaded NLC for Potential Intranasal Administration. Pharmaceutics. 2021;13(8):1166 [Crossref]
69- Alkhamach D, Khan S, Greish K, Hassan H, Haider M. Nanostructured lipid carriers in cancer therapy: Advances in passive and active targeting strategies. International Journal of Pharmaceutics. 2025;678:125736 [Crossref]
70- Porte S, V V, Sengupta D. A Molecular View of Lipid Nanoparticles: Insights into their Morphology and Structural Plasticity. Small. 2025;21(43) [Crossref]
71- Sheikh B, Bhat B, Alshehri B, Mir R, Mir W, Parry Z, Mir M. Nano-Drug Delivery Systems: Possible End to the Rising Threats of Tuberculosis. j biomed nanotechnol. 2021;17(12):2298 [Crossref]
72- Edo G, Moses R, Ali A, Yousif E, Jikah A, Isoje E, Igbuku U, Akpoghelie P, Zainulabdeen K, Essaghah A, Makia R, Ahmed D, Umar H. Natural phenolic compounds for the potential treatment of cancer, mechanistic insights and advances in delivery systems. Next Research. 2025;2(4):100834 [Crossref]
73- Kumar V, Nair S. Nano Lipid Carriers as a Promising Drug Delivery Carrier for Neurodegenerative Disorders - An Overview of Recent Advances. BIOT. 2024;18(1):2 [Crossref]
74- Ferraris C, Rimicci C, Garelli S, Ugazio E, Battaglia L. Nanosystems in Cosmetic Products: A Brief Overview of Functional, Market, Regulatory and Safety Concerns. Pharmaceutics. 2021;13(9):1408 [Crossref]
75- Singh B, Kumar M, Upadhyay P, Singh A. Nanostructured Lipid Carrier for Dermatological Application: A Comprehensive Review and Future Perspective. CNANOM. 2024;14(3):188 [Crossref]
76- Nguyen B, Purnamasari D, Khan N, Park J. A review of state-of-the-art strategies for encapsulating hydrophilic drugs into lipid nanocarriers. J Pharm Investig. 2025; [Crossref]
77- Rao R, Pisay M, Kumar S, Kulkarni S, Pandey A, Kulkarni V, Mutalik S. Medium and large scale preparation of Nanostructured Lipid Carriers of asenapine maleate: Quality-by-design based optimization, production, characterization and performance evaluation. Journal of Drug Delivery Science and Technology. 2022;71:103275 [Crossref]
78- Parveen S, Wadhwa S, Babu M, Vishwas S, Corrie L, Awasthi A, Khan F, Al-Bazi M, Alharthi N, Alotaibi F, Gupta G, Pandey N, Kumar B, Kumbhar P, Disouza J, Gulati M, Neelamraju J, Madempudi R, Dua K, Singh S. Formulation of chrysin loaded nanostructured lipid carriers using Box Behnken design, its characterization and antibacterial evaluation alone and in presence of probiotics co-loaded in gel. Journal of Drug Delivery Science and Technology. 2023;84:104411 [Crossref]
79- Atapour-Mashhad H, Nejabat M, Hadizadeh F, Hoseinsalari A, Golmohammadzadeh S. Preparation, Characterization, and Molecular Dynamic Simulation of Novel Coenzyme Q10 Loaded Nanostructured Lipid Carriers. CPD. 2023;29(27):2177 [Crossref]
80- Wen W, Guo P, Xue H, Lun Wong H. Development of local injectable, bone-targeting nanocarriers of triptolide for treatment of bone-only metastasis. International Journal of Pharmaceutics. 2022;625:122092 [Crossref]
81- Mahapatra M, Mohapatra S, Jena G. Nanostructured Lipid Carriers: A Revolutionary Approach in Antifungal Drug Delivery. Biomedical Materials & Devices. 2026;4(1):189 [Crossref]
82- Stefanov S, Gugleva V, Andonova V. Technological strategies for the preparation of lipid nanoparticles: an updated review. PHAR. 2023;70(3):449 [Crossref]
83- Farasati Far B, Naimi-Jamal M, Sedaghat M, Hoseini A, Mohammadi N, Bodaghi M. Combinational System of Lipid-Based Nanocarriers and Biodegradable Polymers for Wound Healing: An Updated Review. JFB. 2023;14(2):115 [Crossref]
84- de Barros D, Reed P, Alves M, Santos R, Oliva A. Biocompatibility and Antimicrobial Activity of Nanostructured Lipid Carriers for Topical Applications Are Affected by Type of Oils Used in Their Composition. Pharmaceutics. 2021;13(11):1950 [Crossref]
85- Rajoriya V, Gupta R, Vengurlekar S, Surendra Singh U. Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting. International Journal of Pharmaceutics. 2024;655:123986 [Crossref]
86- Parekh K, Mehta T, Dhas N, Kumar P, Popat A. Emerging Nanomedicines for the Treatment of Atopic Dermatitis. AAPS PharmSciTech. 2021;22(2) [Crossref]
87- Nagoba S, Swami A, Deshpande A, Jalindar A, Mali S, Singh S. Pharmacokinetic Profiling and in Vivo Anticancer Evaluation of Abiraterone Acetate Loaded Nanostructured Lipid Carriers. BioNanoSci. 2026;16(3) [Crossref]
88- Prajapati S, Jain A, Bajpai M. Lipid-based nanoformulations in onychomycosis therapy: addressing challenges of current therapies and advancing treatment. RSC Adv. 2025;15(10):7799 [Crossref]
89- Uner B, Ergin A, Ansari I, Macit-Celebi M, Ansari S, Kahtani H. Assessing the In Vitro and In Vivo Performance of L-Carnitine-Loaded Nanoparticles in Combating Obesity. Molecules. 2023;28(20):7115 [Crossref]
90- Jandang W, Ampasavate C, Kiattisin K. Natural Stabilizers and Nanostructured Lipid Carrier Entrapment for Photosensitive Compounds, Curcumin and Capsaicin. Pharmaceutics. 2024;16(3):412 [Crossref]
91- Zeinali S, Moafian Z, Arshad R, Karimi F, Zeinalilathori S, Rahdar A, Fathi-karkan S, Pandey S. Nanomaterials as a Versatile Tool for COVID-19 Treatment. BioNanoSci. 2024;14(4):3950 [Crossref]
92- Ahalwat S, Bhatt D. Development of novel lipid matrix for improved sustained release effect of a hydrophilic drug via response surface methodology. Journal of Drug Delivery Science and Technology. 2022;67:102993 [Crossref]
93- Diril M, Karataş E, Karasulu H. Clobetasol propionate loaded nanostructured lipid carrier gel: formulation strategy and in vitro performance evaluation. Pharmaceutical Development and Technology. 2026;31(2):267 [Crossref]
94- Ramireddy A, Behara D. Development and Optimization of Eberconazole Nanostructured Lipid Carrier Topical Formulations Based on the QbD Approach. AAPS PharmSciTech. 2025;26(4) [Crossref]
95- Rajak P, Kimneiniang N, Sarma S, Bhuyan B, Pathak H. A Comprehensive Overview of Nanoparticles in Acne Management: Current Trends and Future Prospects. COSCI. 2025;04 [Crossref]
96- Desai N, Rana D, Patel M, Bajwa N, Prasad R, Vora L. Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape. Small. 2025;21(29) [Crossref]
97- Schneid A, Azevedo H, de Araújo M. Validation of an RP-HPLC method for simultaneously quantifying three UV filters encapsulated into nanostructured lipid carriers. Anal Methods. 2026;18(8):1732 [Crossref]
98- Bahmanpour A, Mollazadeh-Bajestani M, Ghaffari M, Moztarzadeh F, Sepahvandi A. Hydrogel-Based Formulations for Drug Delivery to the Posterior Segment of the Eye. Ann Biomed Sci Eng. 2023;7(1):038 [Crossref]
99- Ahmed T, Almehmady A, Alharbi W, Alshehri A, Almughem F, Altamimi R, Alshabibi M, Omar A, El-Say K. Incorporation of Perillyl Alcohol into Lipid-Based Nanocarriers Enhances the Antiproliferative Activity in Malignant Glioma Cells. Biomedicines. 2023;11(10):2771 [Crossref]
100- Banik S, Kumar P, Basak P, Goel A, Ohia S, Bagchi M, Chakraborty S, Kundu A, Bagchi D. A critical insight into the physicochemical stability of macular carotenoids with respect to their industrial production, safety profile, targeted tissue delivery, and bioavailability. Toxicology Mechanisms and Methods. 2025;35(3):215 [Crossref]
101- Karati D, Mukherjee S, Prajapati B, Bose A, Paul S, Elossaily G, Roy S. A review on lipid-polymer hybrid nanocarriers in cancer. Journal of Drug Delivery Science and Technology. 2024;97:105827 [Crossref]
102- Hajleh M, Nsairat H, Al-Halaseh L, Al-Samydai A, Ibrahim A, Al-Dujaili E. Permeation Enhancers for Enhanced Topical Delivery of Pharmaceutical and Cosmeceutical Products. 2025;29(1):1 [Crossref]
103- Patera Nugraha A, Olivia Yudianto D, Aisyiah Anwar A, Eka Purnamasari A, Ananda Mappananrang R, Faradilla N, Ramadhani R, Muhammad L, Binti Tengku Ahmad Noor T, Putera Nugraha A, Pratama Nugraha A. Potential of Curcumin-Quercetin Loaded Nanostructured Lipid Carriers as Oral Squamous Cell Carcinoma Adjuvant Therapy by Downregulating AKT/PI3K Signaling Pathway. RJPT. 2022;:5353 [Crossref]
104- Ghosh S, Tiwari T, Nagaich U, Jain N. A Detailed Insight into Nanostructured Lipid Carriers: A Versatile Drug Delivery System. NANOTEC. 2023;17(4):284 [Crossref]
105- Yeerong K, Czyrski G, Heinz A, Müllertz A, Rades T, Chaiyana W. Transdermal delivery of Acheta domesticus protein hydrolysate using nanostructured lipid carriers and Derma Stamp ― Does the combination of lipid-based formulation and a physical technique add value for permeation and retention?. Journal of Drug Delivery Science and Technology. 2025;104:106470 [Crossref]
106- Kheirkhah S, Abedi M, Zare F, Salmanpour M, Abolmaali S, Tamaddon A. Surface engineered palmitoyl-mesoporous silica nanoparticles with supported lipid bilayer coatings for high-capacity loading and prolonged release of dexamethasone: A factorial design approach. Journal of Drug Delivery Science and Technology. 2022;78:103943 [Crossref]
107- Banazadeh M, Behnam B, Ganjooei N, Gowda B, Kesharwani P, Sahebkar A. Curcumin-based nanomedicines: A promising avenue for brain neoplasm therapy. Journal of Drug Delivery Science and Technology. 2023;89:105040 [Crossref]
108- Xu L, Wang X, Liu Y, Yang G, Falconer R, Zhao C. Lipid Nanoparticles for Drug Delivery. Advanced NanoBiomed Research. 2022;2(2) [Crossref]
109- Lazzarotto Rebelatto E, Rauber G, Caon T. An update of nano-based drug delivery systems for cannabinoids: Biopharmaceutical aspects & therapeutic applications. International Journal of Pharmaceutics. 2023;635:122727 [Crossref]
110- Yadavalli T, Ames J, Wu D, Ramirez B, Bellamkonda N, Shukla D. Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform. European Journal of Pharmaceutics and Biopharmaceutics. 2022;173:150 [Crossref]
111- Crintea A, Dutu A, Sovrea A, Constantin A, Samasca G, Masalar A, Ifju B, Linga E, Neamti L, Tranca R, Fekete Z, Silaghi C, Craciun A. Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation. Nanomaterials. 2022;12(8):1376 [Crossref]
112- Zoulikha M, He W. Targeted Drug Delivery for Chronic Lymphocytic Leukemia. Pharm Res. 2022;39(3):441 [Crossref]
113- Holler N, Ruseska I, Schachner-Nedherer A, Zimmer A, Petschacher C. Oral Treatment of Obesity by GLP-1 and Its Analogs. Pharmaceutics. 2025;17(12):1596 [Crossref]
114- Kim S, Puranik N, Yadav D, Jin J, Lee P. Lipid Nanocarrier-Based Drug Delivery Systems: Therapeutic Advances in the Treatment of Lung Cancer. IJN. 2023;Volume 18:2659 [Crossref]
115- Thiruchenthooran V, Espina M, Świtalska M, Bonilla-Vidal L, Wietrzyk J, Garcia M, Souto E, Sánchez-López E, Gliszczyńska A. Combination of Indomethacin with Nanostructured Lipid Carriers for Effective Anticancer Therapy. IJN. 2024;Volume 19:7033 [Crossref]
116- Shahiwala A. Physiological Determinants and Plausible ‘6R’ Roadmap for Clinical Success of Nanomedicines. Nanomedicine (Lond). 2023;18(18):1207 [Crossref]
117- Husain A, Kushwaha P, Kapoor A, Singh P. Exploring the Therapeutic Potential of Lipid Nanocarriers in Psoriasis Management: Advances and Applications. AAPS PharmSciTech. 2025;26(7) [Crossref]
118- Bayraktar E, Bayraktar R, Oztatlici H, Lopez-Berestein G, Amero P, Rodriguez-Aguayo C. Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update. ncRNA. 2023;9(2):27 [Crossref]
119- Singh C, Rai P, Kumar M, Tiwari V, Tiwari A, Sharma A, Sharma K. Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics. PNT. 2024;12(2):126 [Crossref]
120- Gupta C, Yadav H, Dhanwani I, Gulati S. Theranostic Applications of Tailored Lipid-based Nanoparticles as Drug Delivery Systems for Cancer Treatment. ACS Appl Nano Mater. 2025;8(41):19679 [Crossref]
121- Eroğlu C, Sinani G, Ulker Z. Current State of Lipid Nanoparticles (SLN and NLC) for Skin Applications. CPD. 2023;29(21):1632 [Crossref]
122- Wolf A, Volz‐Rakebrand P, Balke J, Alexiev U. Diffusion Analysis of NAnoscopic Ensembles: A Tracking‐Free Diffusivity Analysis for NAnoscopic Ensembles in Biological Samples and Nanotechnology. Small. 2023;19(16) [Crossref]
123- Zembala J, Forma A, Zembala R, Januszewski J, Zembala P, Adamowicz D, Teresiński G, Buszewicz G, Flieger J, Baj J. Technological Advances in a Therapy of Primary Open-Angle Glaucoma: Insights into Current Nanotechnologies. JCM. 2023;12(18):5798 [Crossref]
124- Chaiyasut C, Sivamaruthi B, Jungsinyatam P, Tansrisook C, Jinarat D, Chaiyasut K, Peerajan S, Rungseevijitprapa W. Development and Evaluation of Elaeagnus rhamnoides (L.) A. Nelson Oil-Loaded Nanostructured Lipid Carrier for Improved Skin Hydration. Applied Sciences. 2022;12(16):8324 [Crossref]
125- Malhotra S, Jindal S, Bala R, Madaan R. Liposome as a Potential Drug Delivery System in Addressing Skin Diseases: A Review. CDTH. 2025;20(3):332 [Crossref]
126- Sanadgol N, Abedi M, Hashemzaei M, Kamran Z, Khalseh R, Beyer C, Voelz C. Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges. J Nanobiotechnol. 2025;23(1) [Crossref]
127- Tariq A, Kazim T, Khan M, Usman M, Khan A. Reshaping antibiotic delivery: Chitosan‐based polymeric hydrogel for transdermal treatment of drug resistant bacteria. Polymers for Advanced Techs. 2024;35(3) [Crossref]
128- Tarahi M, Singh M, Farahnaky A, Ghasemlou M, Dokouhaki M. Plant-based delivery systems for bioactive compounds: Mechanisms of release and functional food applications. Advances in Colloid and Interface Science. 2026;350:103787 [Crossref]
129- Raj A, Nirbhavane P, Gandhi H, Yadav S, Kalra A, Sardana S. Quality by design-driven approach to develop a nanocarrier-based sulfasalazine topical system for rheumatoid arthritis management. Drug Development and Industrial Pharmacy. 2026;:1 [Crossref]
130- Thiruchenthooran V, Świtalska M, Maciejewska G, Palko-Łabuz A, Bonilla-Vidal L, Wietrzyk J, Souto E, Sánchez-López E, Gliszczyńska A. Multifunctional Indomethacin Conjugates for the Development of Nanosystems Targeting Cancer Treatment. IJN. 2024;Volume 19:12695 [Crossref]
131- Damayanti N, Khong N, Liew C, Chutoprapat R. Surfactant Ratio-Driven Modulation of Caffeine Loading and Release in Nigella sativa Oil Nanostructured Lipid Carriers. ACS Omega. 2025;10(47):57306 [Crossref]
132- Yadav A, Yadav N, Rawat R, Sharma S, Gupta T, Prasad D. Advancing Cefuroxime Axetil through Nanotechnology: Enhancing Its Effectiveness. J Bio-X Res. 2024;7 [Crossref]
133- Chavan M, Pingale R, Bhairav B. Development and In-Vitro Characterization of Luteolin-Loaded Nanostructured Lipid Carrier. Biotech Res Asia 2025;22(4). 2025;4(22):1619 [Crossref]
134- Garg J, Pathania K, Sah S, Pawar S. Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Futur J Pharm Sci. 2022;8(1) [Crossref]
135- Putchakayala N, Morusu K, Ramisetty S, Ravoru N. Nanostructured Lipid Carriers: A Novel Platform in the Formulation of Targeted Drug Delivery Systems. CNANOM. 2025;15(1):26 [Crossref]
136- Vu N, Pham N, Tran T, Pham X, Ngo D, Nguyen M. Possibility of nanostructured lipid carriers encapsulating astaxanthin from Haematococcus pluvialis to alleviate skin injury in radiotherapy . International Journal of Radiation Biology. 2024;100(2):209 [Crossref]
137- Izza N, Watanabe N, Okamoto Y, Suga K, Wibisono Y, Kajimura N, Mitsuoka K, Umakoshi H. Dependence of the Core–Shell Structure on the Lipid Composition of Nanostructured Lipid Carriers: Implications for Drug Carrier Design. ACS Appl Nano Mater. 2022;5(7):9958 [Crossref]
138- K M A, Angolkar M, Rahamathulla M, Thajudeen K, Ahmed M, Farhana S, Shivanandappa T, Paramshetti S, Osmani R, Natarajan J. Box-Behnken Design-Based Optimization and Evaluation of Lipid-Based Nano Drug Delivery System for Brain Targeting of Bromocriptine. Pharmaceuticals. 2024;17(6):720 [Crossref]
139- Far B, Safaei M, Pourmolaei A, Adibamini S, Shirdel S, Shirdel S, Emadi R, Kaushik A. Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer’s Diseases. ACS Appl Bio Mater. 2024;7(6):3535 [Crossref]
140- Sun Y, Wang C, Li X, Lu J, Wang M. Recent advances in drug delivery of celastrol for enhancing efficiency and reducing the toxicity. Front Pharmacol. 2024;15 [Crossref]
141- Md S, Ibrahim I, Al-Rabia M, Iqubal M, Warsi M. Development of Turmeric Oil-based 5-Fluorouracil Loaded Lipid Nanogel for Improved Dermatokinetic and Drug Deposition for Skin Cancer. J Oleo Sci. 2025;74(12):1091 [Crossref]
142- Pujari P, Shinde A, Shedmake A, Jalindar A, Mali S, Singh S. Rutin-Loaded Nanostructured Lipid Carriers incorporated Hydrogel for the Management Psoriasis: In Vitro and In Vivo Assessment. BioNanoSci. 2026;16(1) [Crossref]
143- Wang L, Dekker M, Heising J, Zhao L, Fogliano V. Food matrix design can influence the antimicrobial activity in the food systems: A narrative review. Critical Reviews in Food Science and Nutrition. 2024;64(25):8963 [Crossref]
144- Jain A, Jain S, Abourehab M, Mehta P, Kesharwani P. An insight on topically applied formulations for management of various skin disorders. Journal of Biomaterials Science, Polymer Edition. 2022;33(18):2406 [Crossref]
145- EL-Zahaby S, Wen M, Abdelwahab I, Shahine Y, Abdelhady S, Elbatouti G. Eco-friendly Nanostructured Liquid Crystals Loaded with Clove Oil as a Sustainable Approach for Managing Infected Burn Wounds. AAPS PharmSciTech. 2024;26(1) [Crossref]
146- Yao W, Lin Y, Weng Y, Wu Y, Zheng L, Zheng D, Xi Q, Zhao J. Lipid‐Based Nanoparticles in Cancer Therapy: Advances in Targeted Drug Delivery and Therapeutic Potential for Renal Cell Carcinoma. Advanced Science. 2025;12(36) [Crossref]
147- Cai X, Drummond C, Zhai J, Tran N. Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer. Adv Funct Materials. 2024;34(41) [Crossref]
148- Sargazi S, Arshad R, Ghamari R, Rahdar A, Bakhshi A, Karkan S, Ajalli N, Bilal M, Díez‐Pascual A. siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review. Cell Biology International. 2022;46(9):1320 [Crossref]
149- Priya S, Desai V, Singhvi G. Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery. ACS Omega. 2023;8(1):74 [Crossref]
150- Badarinadh K, Chauhan S, Singh I. Cutaneous Lupus Erythematosus Treatment Revolution: Exploring the Latest Nano Lipid Drug Delivery Innovations. NANOASIA. 2024;14(4) [Crossref]
151- Soni S, Maheshwari R, Sah A. Nanostructured Lipid Carrier: Beneficial Role in Oral Drug Delivery System. BioNanoSci. 2024;14(4):3988 [Crossref]
152- Singh S, Tiwary N, Sharma N, Behl T, Antil A, Anwer M, Ramniwas S, Sachdeva M, Elossaily G, Gulati M, Ohja S. Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management. Pharmaceuticals. 2024;17(2):248 [Crossref]
153- Fan Y, Yang Z. Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application. Pharmaceutics. 2022;14(6):1193 [Crossref]
154- Javed S, Mangla B, Salawi A, Sultan M, Almoshari Y, Ahsan W. Essential Oils as Dermocosmetic Agents, Their Mechanism of Action and Nanolipidic Formulations for Maximized Skincare. Cosmetics. 2024;11(6):210 [Crossref]
155- Sultan M, Almoshari Y, Mohan S, Al-Kasim M, Alyami H, Ansari M, Alam M. Capecitabine-loaded NLC for Breast Cancer Treatment: Preparation, Characterization, and In vitro Evaluation. CDD. 2025;22(7):968 [Crossref]
156- Myo N, Kamwa R, Jamnong T, Swasdipisal B, Somrak P, Rattanamalakorn P, Neatsawang V, Apiwatsiri P, Yata T, Hampson D, Prapasarakul N. Metabolomic profiling and antibacterial efficacy of probiotic-derived cell-free supernatant encapsulated in nanostructured lipid carriers against canine multidrug-resistant bacteria. Front Vet Sci. 2025;11 [Crossref]
157- Singh A, Sharma S, Gaur P, Gupta D. Fabrication of Mupirocin-Loaded Nanostructured Lipid Carrier and Its In Vitro Characterization. ASSAY and Drug Development Technologies. 2021;19(4):216 [Crossref]
158- Kyriakoudi A, Spanidi E, Mourtzinos I, Gardikis K. Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications. Plants. 2021;10(6):1238 [Crossref]
159- Suhandi C, Wilar G, Mohammed A, Mahmoud S, Muchtaridi M, Shamsuddin S, Safuan S, Lesmana R, Hasan N, Zulhendri F, Wathoni N. Propolis-Based Nanostructured Lipid Carrier of α-Mangostin for Promoting Diabetic Wound Healing in Alloxan-Induced Mice. JIR. 2025;Volume 18:7443 [Crossref]
160- Ramkar S, Suresh P. Targeting Potential of Zinc Oxide Nanoparticles and Finasteride-loaded Nano Lipidic Carriers-infused Topical Gel - In vitro and In vivo Skin Permeation Studies. Scopus Indexed. 2023;16(6):7030 [Crossref]
161- Chutoprapat R, Kopongpanich P, Chan L. A Mini-Review on Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Topical Delivery of Phytochemicals for the Treatment of Acne Vulgaris. Molecules. 2022;27(11):3460 [Crossref]
162- Fan M, Zheng J, Huang Y, Lu H, Lu M. Efficacy and hepatotoxicity of tamoxifen-loaded fructose-based nanodrug for breast cancer treatment. J Mater Chem B. 2025;13(27):8229 [Crossref]
163- Muteeb G, Khafaga D, El-Morsy M, Farhan M, Aatif M, Hosney M. Targeting tumor-associated macrophages with nanocarrier-based treatment for breast cancer: A step toward developing innovative anti-cancer therapeutics. Heliyon. 2024;10(18):e37217 [Crossref]
164- Singh A, Iqubal M, Mittal S, Qizilbash F, Sartaz A, Kumar S, Ali J, Baboota S. Designing and evaluation of dermal targeted combinatorial nanostructured lipid carrier gel loaded with curcumin and resveratrol for accelerating cutaneous wound healing. Particulate Science and Technology. 2024;42(1):88 [Crossref]
165- Felimban R, Tayeb H, Chaudhary A, Felemban M, Alnadwi F, Ali S, Alblowi J, ALfayez E, Bukhary D, Alissa M, Qahl S. Utilization of a nanostructured lipid carrier encapsulating pitavastatin– Pinus densiflora oil for enhancing cytotoxicity against the gingival carcinoma HGF-1 cell line . Drug Delivery. 2023;30(1):83 [Crossref]
166- Zeng L, Gowda B, Ahmed M, Abourehab M, Chen Z, Zhang C, Li J, Kesharwani P. Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Mol Cancer. 2023;22(1) [Crossref]
167- Mehta M, Bui T, Yang X, Aksoy Y, Goldys E, Deng W. Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development. ACS Mater Au. 2023;3(6):600 [Crossref]
168- Anwar W, Kassem A, Salama A, Zidan M, Ibrahim A, Elbahwy I, Barakat E, Faris T, Elsayad M, Samy A, Elsayed M, Abdelaziz A. Optimisation of albendazole delivery and assessment of anticancer potential in hepatocellular carcinoma (HepG2 cells) using surface modified nanostructured lipid carriers. Journal of Microencapsulation. 2025;42(2):161 [Crossref]
169- Chaudhuri A, Kumar D, Srivastava S, Kumar D, Patil U, Parmar A, Singh S, Agrawal A. Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach. Pharmaceutics. 2024;16(7):926 [Crossref]
170- Sartaj A, Nabi B, Iqubal A, Aggarwal N, Haider K, Baboota S, Ali J. Development and Characterization of Oral Efavirenz-Loaded Nanostructured Lipid Carriers and Their Optimization with Box–Behnken Design Approach for the Neurological Disorder. ASSAY and Drug Development Technologies. 2025;23(2):84 [Crossref]
171- Rofeal M, Abdelmalek F, Steinbüchel A. Naturally-Sourced Antibacterial Polymeric Nanomaterials with Special Reference to Modified Polymer Variants. IJMS. 2022;23(8):4101 [Crossref]
172- Anjali P, Jawahar N, Praharsh Kumar M, Jubie S, Selvamuthukumar S. Nanocarriers in the treatment of epilepsy: Challenges and opportunities. Journal of Drug Delivery Science and Technology. 2024;97:105788 [Crossref]
173- Prajapati P, Patel M, Kansara Y, Shah P, Pulusu V, Shah S. Green LC-MS/MS method for in-vivo pharmacokinetics of mirabegron-encapsulated nanostructured lipid carriers in rat plasma: Integrating white analytical chemistry and analytical quality by design approach. Sustainable Chemistry and Pharmacy. 2024;39:101523 [Crossref]
174- Yasir Siddique M, Ashraf A, Khan S, Saleem M, Ashfaq M, Alam K, Ibrahim A, Nazar M. Formulation of Microemulsion-Based Gels for Enhanced Topical Administration of Nonsteroidal Anti-Inflammatory Drugs. Langmuir. 2024;40(45):24174 [Crossref]
175- Nasirzadeh Fard Y, Kelidari H, Kazeminejad A, Mousavi S, Hedayati M, Mosayebi E, Nabili M, Faeli L, Asare-Addo K, Nokhodchi A, Moazeni M. Enhanced treatment in cutaneous dermatophytosis management by Zataria multiflora-loaded nanostructured lipid carrier topical gel: A randomized double-blind placebo-controlled clinical trial. Journal of Drug Delivery Science and Technology. 2023;80:104132 [Crossref]
176- Khare P, Edgecomb S, Hamadani C, Tanner E, S Manickam D. Lipid nanoparticle-mediated drug delivery to the brain. Advanced Drug Delivery Reviews. 2023;197:114861 [Crossref]
177- Lima S, Freire M, Oliveira V, Solisio C, Converti A, de Lima Á. Astaxanthin Delivery Systems for Skin Application: A Review. Marine Drugs. 2021;19(9):511 [Crossref]
178- Alloush T, Demiralp B. A Review of Formulation Strategies for Cyclodextrin-Enhanced Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs). IJMS. 2025;26(13):6509 [Crossref]
179- Hoseinsalari A, Atapour-Mashhad H, Asili J, Tayarani-Najaran Z, Mohtashami L, Khanavi M, Vazirian M, Akbari Javar H, Niknam S, Golmohammadzadeh S, Ardekani M. Preparation and Characterization of Nanostructured Lipid Carriers (NLCs) Containing Glycyrrhiza glabra Extract for the Treatment of Skin Hyperpigmentation. CPD. 2024;30(40):3213 [Crossref]
180- Rajak P, Karmakar A, Sarma S, Bhuyan B. Topical Administration of Nanostructured Lipid Carriers as a Viable Approach to Reduce Inflammation: A Review. AIAAMC. 2025;24(1):26 [Crossref]
181- Sharma P, Sharma T, Bashir B, Andotra N, Awasthi A, Patel P, Subramaniyan V, Chellappan D, Gupta G, Vishwas S, Singh S. Role of Galangin for the Treatment of Alzheimer’s Disease: Journey So Far and Road Ahead. Curr Nutr Rep. 2025;14(1) [Crossref]
182- Ghurghure S, Jadhav T, Kale S, Phatak A. Formulation and evaluation of posaconazole loaded nanostructured lipid carriers for topical drug delivery system. CTPPC. 2022;4(3):126 [Crossref]
183- S, Singla M, Gupta S, Porwal O, Nasser Binjawhar D, Sayed A, Mittal P, El-Demerdash F, Algahtani M, Singh S, Dua K, Gupta G, Bawa P, Altyar A, Abdel-Daim M. Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington’s disease via the nasal-brain route. Front Pharmacol. 2023;14 [Crossref]
184- Singh S, Sharma H, Arumugam M, Gupta G, Panth N, Kulkarni M, De Rubis G, Oliver B, Paudel K, Pandey N, Hussain M, Kumbhar P, Disouza J, Dua K, Singh S. Box–Behnken-designed nanostructured lipid carriers of xanthohumol for enhanced cellular uptake in human lung cancer cell line A549: formulation, optimization, characterization, and cytotoxicity assessment. Med Oncol. 2025;42(11) [Crossref]
185- AL-Haj W, Nsairat H, El-Tanani M. Pimozide-loaded nanostructured lipid carriers: Repurposing strategy against lung cancer. Science Progress. 2024;107(4) [Crossref]
186- Iordache T, Badea N, Mihaila M, Crisan S, Pop A, Lacatusu I. Polygonum cuspidatum Loaded Nanostructured Lipid Carriers for Dual Inhibition of TNF-α- and IL-6 Cytokines and Free Radical Species. Materials. 2023;16(9):3492 [Crossref]
187- Vaiss D, Dias D, Yurgel V, Araujo F, Porto L, Burkert J, Marinho M, Filgueira D, Dora C. Design and Factorial Optimization of Curcumin and Resveratrol Co-Loaded Lipid Nanocarriers for Topical Delivery. Pharmaceutics. 2026;18(1):109 [Crossref]
188- Aryani N, Siswodihardjo S, Soeratri W, Sari N. Development, characterization, molecular docking, and in vivo skin penetration of coenzyme Q10 nanostructured lipid carriers using tristearin and stearyl alcohol for dermal delivery. 2021;32(4):517 [Crossref]
189- Liang C, Liu X, Sun Z, Wen L, Wu J, Shi S, Liu X, Luo N, Li X. Lipid nanosystems for fatty liver therapy and targeted medication delivery: a comprehensive review. International Journal of Pharmaceutics. 2025;669:125048 [Crossref]
190- Darvishi M, Khan M, Mohapatra S, Singh M, Ali A, Rajabalizadeh S, Rahman H, Iqbal Z, Mirza M. Nanotools as potential approach in effective management of acne. Journal of Drug Delivery Science and Technology. 2024;102:106380 [Crossref]
191- da Silva N, Colodi F, Pedrão M, Celligoi M. Encapsulating Biosurfactants in Biopolymers for Innovative Applications in the Food Industry. ACS Food Sci Technol. 2024;4(11):2528 [Crossref]
192- Kamel A, Gabr S, Preis E, Engelhardt K, Amin M, Bakowsky U, Schäfer J. Towards digital transformation: A Quality by Design approach to plant-based nanostructured lipid carriers formulation. International Journal of Pharmaceutics. 2025;681:125797 [Crossref]
193- Pucci C, Martinelli C, Degl'Innocenti A, Desii A, De Pasquale D, Ciofani G. Light‐Activated Biomedical Applications of Chlorophyll Derivatives. Macromolecular Bioscience. 2021;21(9) [Crossref]
194- Ashfaq R, Kovács A, Berkó S, Katona G, Paróczai D, Szécsényi M, Burián K, Vályi P, Veres K, Girst G, Hunyadi A, Polgár T, Budai-Szűcs M. Co-encapsulated apigenin and clove oil in nanostructured lipid carriers for enhanced periodontal disease therapy. Journal of Drug Delivery Science and Technology. 2026;115:107644 [Crossref]
195- Zaib S, Saeed Shah H, Usman F, Shahzadi K, Mazhar Asjad H, Khan R, Dera A, Adel Pashameah R, Alzahrani E, Farouk A, Khan I. Green Synthesis of Gelatin‐Lipid Nanocarriers Incorporating Berberis aristata Extract for Cancer Therapy; Physical Characterization, Pharmacological and Molecular Modeling Analysis. ChemistrySelect. 2022;7(45) [Crossref]
196- Mall J, Naseem N, Haider M, Rahman M, Khan S, Siddiqui S. Nanostructured lipid carriers as a drug delivery system: A comprehensive review with therapeutic applications. Intelligent Pharmacy. 2025;3(4):243 [Crossref]
197- Ordoyo-Pascual J, Ruiz-Alonso S, Gallego I, Saenz-del-Burgo L, Pedraz J. Effects of beta and gamma radiation sterilization on growth factor-loaded nanoparticles: an innovative approach for osteoarticular disorders treatment. Drug Deliv and Transl Res. 2025;15(10):3716 [Crossref]
198- Singh V, Rehman U, Alqahtani T, Shmrany H, Gupta G, Goh K, Kesharwani P. Interface‐Engineered Nanocarriers for Translational and Patient‐Centric Topical Therapy in Psoriasis. Drug Development Research. 2026;87(1) [Crossref]
199- Hussain M, Hafeez A, Kushwaha S. Nanoformulation mediated transdermal delivery of anti-diabetic drugs: an updated review. Intelligent Pharmacy. 2023;1(4):192 [Crossref]
200- Phadke A, Amin P. A Recent Update on Drug Delivery Systems for Pain Management. Journal of Pain & Palliative Care Pharmacotherapy. 2021;35(3):175 [Crossref]
201- Unnisa A, Chettupalli A, Alazragi R, Alelwani W, Bannunah A, Barnawi J, Amarachinta P, Jandrajupalli S, Elamine B, Mohamed O, Hussain T. Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations. Pharmaceuticals. 2023;16(8):1151 [Crossref]
202- Parveen F, Madni A, Torchilin V, Rehman M, Jamshaid T, Filipczak N, Rai N, Khan M, Khan M. Investigation of Eutectic Mixtures of Fatty Acids as a Novel Construct for Temperature-Responsive Drug Delivery. IJN. 2022;Volume 17:2413 [Crossref]
203- Ojha S, Mishra S. Nanostructured Lipid Carriers for Targeting Central Nervous System: Recent Advancements. MNS. 2023;15(2):82 [Crossref]
204- Abaza T, Mohamed E, Zaky M. Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy. Med Oncol. 2025;42(9) [Crossref]
205- Alquraisy A, Ramadhani K, Mohammed A, Wilar G, Osman W, Elamin K, Wathoni N. Nanostructured Lipid Carrier-Gels for Wound Healing: A Narrative Review of Formulation Strategies, Mechanisms, and Translational Potential. NSA. 2026;Volume 19:1 [Crossref]
206- Shah S, Patel A, Prajapati B, Alexander A, Pandya V, Trivedi N, Pandey P, Patel S, Patel R. Multifaceted nanolipidic carriers: a modish stratagem accentuating nose-to-brain drug delivery. J Nanopart Res. 2023;25(7) [Crossref]
207- Sharma N, Kumar S, Joshi G, Choudhary D. Formulation and Characterization of Febuxostat Loaded Nanostructured Lipid Carriers (NLCs) - Gel for Topical Treatment of Gout. NANOTEC. 2022;16(3):250 [Crossref]
208- Ahmadi M, Mehdikhani M, Varshosaz J, Farsaei S, Torabi H. Pharmaceutical evaluation of atorvastatin-loaded nanostructured lipid carriers incorporated into the gelatin/hyaluronic acid/polycaprolactone scaffold for the skin tissue engineering. J Biomater Appl. 2021;35(8):958 [Crossref]
209- Molla A. Biobased Nanomaterials in Drug Delivery System: Current Trends and Future Prospectives . NANO. 2025;13(2):35 [Crossref]
210- Jiang W, Badehnoosh B, Ruan W. Food-grade nanostructured delivery systems for oral administration of astaxanthin: Bioprocessing strategies and therapeutic applications. npj Sci Food. 2025;10(1) [Crossref]
211- Attanayake S, Nguyen M, Chanda A, Alonso J, Orue I, Lee T, Srikanth H, Phan M. Superparamagnetic Superparticles for Magnetic Hyperthermia Therapy: Overcoming the Particle Size Limit. ACS Appl Mater Interfaces. 2025;17(13):19436 [Crossref]
212- Mahmoud K, Swidan S, El-Nabarawi M, Teaima M. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. J Nanobiotechnol. 2022;20(1) [Crossref]
213- Javed S, Mangla B, Almoshari Y, Sultan M, Ahsan W. Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. 2022;11(1):1744 [Crossref]
214- Puri A, Mohite P, Munde S, Ade N, Ramole A, Pillai D, Nagare S, Mahadik S, Singh S. Unlocking the multifaceted potential of lipid-based dispersion as a drug carrier: Targeted applications and stability improvement strategies. Journal of Dispersion Science and Technology. 2025;:1 [Crossref]
215- Kenechukwu F, Ugwu K, Chukwu G, Anikwe C, Okaudu M, Momoh M, Ricci-Junior E, Attama A. Transdermal Films and Nanogels as Toolboxes for Novel Generation of Non-invasive Antimalarial Pharmaceuticals in Dermatology: A Comprehensive Review. Biomedical Materials & Devices. 2026;4(2):1924 [Crossref]
216- Khodaverdi H, Zeini M, Moghaddam M, Vazifedust S, Akbariqomi M, Tebyaniyan H. Lipid-based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review. CDD. 2022;19(10):1012 [Crossref]
217- Lima E, dos Santos D, Souza A, Macedo M, Bandeira M, Junior S, Fiuza B, Rocha V, dos Santos Fonseca L, Nunes D, Hodel K, Machado B. RNA Combined with Nanoformulation to Advance Therapeutic Technologies. Pharmaceuticals. 2023;16(12):1634 [Crossref]
218- Prema R, Prabhakaran M, Meenakshi M, Sankar C. A Comprehensive Review on Nanostructured Lipid Carriers. J Drug Delivery Ther. 2025;15(10):172 [Crossref]
219- Jeitler R, Glader C, Tetyczka C, Zeiringer S, Absenger-Novak M, Selmani A, Fröhlich E, Roblegg E. Investigation of Cellular Interactions of Lipid-Structured Nanoparticles With Oral Mucosal Epithelial Cells. Front Mol Biosci. 2022;9 [Crossref]
220- Chen J, Cong X. Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects. Biomedicine & Pharmacotherapy. 2023;157:113998 [Crossref]
221- P, M, Q, H. Recent Strategies for Enhancing the Solubility and Dissolution of Poorly Water-Soluble Curcumin for Therapeutic Purposes and Beyond. 2025;7(9) [Crossref]
222- Garg N, Tandel N, Bhadada S, Tyagi R. Nanostructured Lipid Carrier–Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases. Front Pharmacol. 2021;12 [Crossref]
223- Silviandari P, Raharjo S, Setiowati A. Optimization and Characterization of a Nanostructured Lipid Carrier Containing α-Tocopherol/Tocotrienol Prepared using Rice Bran Oil and Palm Kernel Stearin. CNF. 2024;21(1):67 [Crossref]
224- Yadav H, Rathore S, Gupt R. Nanotechnology in Pharmacy: A Comprehensive Review of Emerging Trends and Applications. ijnrph. 2025;:108 [Crossref]
225- Kumari M, Gohil D, Sadhu P. Nanostructured lipid carriers for topical drug delivery: A comprehensive review of design, mechanisms, and therapeutic advances. Next Nanotechnology. 2026;9:100367 [Crossref]
226- Bazán Henostroza M, Diniz Tavares G, Nishitani Yukuyama M, De Souza A, José Barbosa E, Carlos Avino V, dos Santos Neto E, Rebello Lourenço F, Löbenberg R, Araci Bou-Chacra N. Antibiotic-loaded lipid-based nanocarrier: A promising strategy to overcome bacterial infection. International Journal of Pharmaceutics. 2022;621:121782 [Crossref]
227- Zazuli Z, Hartati R, Rowa C, Asyarie S, Asyarie S. The Potential Application of Nanocarriers in Delivering Topical Antioxidants. Pharmaceuticals. 2025;18(1):56 [Crossref]
228- Kukreja T, Saraf S. Atopic Dermatitis: A Review on Nanocarrier-based Dermo-pharmaceutical Formulation for Inflammatory Effect. CIS. 2025;03 [Crossref]
229- Wairkar S, Patel D, Singh A. Nanostructured lipid carrier based dermal gel of cyclosporine for atopic dermatitis-in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology. 2022;72:103365 [Crossref]
230- Izza N, Suga K, Okamoto Y, Watanabe N, Bui T, Wibisono Y, Fadila C, Umakoshi H. Systematic Characterization of Nanostructured Lipid Carriers from Cetyl Palmitate/Caprylic Triglyceride/Tween 80 Mixtures in an Aqueous Environment. Langmuir. 2021;37(14):4284 [Crossref]
231- Ndemazie N, Inkoom A, Morfaw E, Smith T, Aghimien M, Ebesoh D, Agyare E. Multi-disciplinary Approach for Drug and Gene Delivery Systems to the Brain. AAPS PharmSciTech. 2022;23(1) [Crossref]
232- Gugleva V, Andonova V. Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms. Pharmaceuticals. 2023;16(3):474 [Crossref]
233- Mathew Thevarkattil A, Yousaf S, Houacine C, Khan W, Bnyan R, Elhissi A, Khan I. Anticancer drug delivery: Investigating the impacts of viscosity on lipid-based formulations for pulmonary targeting. International Journal of Pharmaceutics. 2024;664:124591 [Crossref]
234- Bruzinga C, Bauer C, Schmitz C, Gerber T, Rodrigues E, Ziech C, Ramirez N, Miranda C, Mendes M, Arruda F, Heindrickson J, Ramos F, Gomes I, Gasparotto M, Cavalcante C, Dutra S, Vieira F, Mazzarino L, Veleirinho M, Maraschin M. Development and stability analysis of a lipid-based astaxanthin nanoemulsion, its application and effect on the immune response and survival of the Pacific white shrimp. Front Nanotechnol. 2026;8 [Crossref]
235- Achagar R, Ait-Touchente Z, El Ati R, Boujdi K, Thoume A, Abdou A, Touzani R. A Comprehensive Review of Essential Oil–Nanotechnology Synergy for Advanced Dermocosmetic Delivery. Cosmetics. 2024;11(2):48 [Crossref]
236- Hajla A, Al-Khuraiji A, El-Nagar D, Al-Malahi N, Alanazi I, Abdel-Gaber R. Anti-Cancer Efficacy of Acacia nilotica Nanoparticles: Apoptosis Induction and Tumor Regression in a DMBA-induced Breast Cancer Rat Model . Pharmacognosy Magazine. 2025;21(4):1390 [Crossref]
237- Garcia C, Rad A, Saeedinejad F, Manojkumar A, Roy D, Rodrigo H, Chew S, Rahman Z, Nieh M, Roy U. Effect of Drug-To-Lipid Ratio on Nanodisc-Based Tenofovir Drug Delivery to The Brain for HIV-1 Infection. Nanomedicine (Lond). 2022;17(13):959 [Crossref]
238- Elkhateeb O, Badawy M, Tohamy H, Abou-Ahmed H, El-Kammar M, Elkhenany H. Curcumin-infused nanostructured lipid carriers: a promising strategy for enhancing skin regeneration and combating microbial infection. BMC Vet Res. 2023;19(1) [Crossref]
239- Ranch K, Patel Y, Acharya E, Gupta P, Singh A, Singh S. Enhanced Ocular Delivery of Epalrestat Using Nanostructured Lipid Carrier Laden Soft Contact Lens. Pharmaceutics. 2025;17(12):1515 [Crossref]
240- Garbati P, Picco C, Magrassi R, Signorello P, Cacopardo L, Dalla Serra M, Faticato M, De Luca M, Balestra F, Scavo M, Viti F. Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers. Pharmaceutics. 2024;16(3):431 [Crossref]
241- Rahman M, Jalouli M, Bhajan S, Al-Zharani M, Harrath A. A Comprehensive Review of Nanoparticle-Based Drug Delivery for Modulating PI3K/AKT/mTOR-Mediated Autophagy in Cancer. IJMS. 2025;26(5):1868 [Crossref]
242- Ibrahim M, Elsayyad N, Salama A, Noshi S. Utilization of response surface design for development and optimization of rosuvastatin calcium-loaded nano-squarticles for hair growth stimulating VEGF and IGF production: in-vitro and in-vivo evaluation . Drug Development and Industrial Pharmacy. 2023;49(9):580 [Crossref]
243- Morrison E, Guo M, Maia J, Nelson D, Swaminathan S, Kandimalla K, Lee H, Zasadzinski J, McCormick A, Marti J, Garhofer B. Dense nanolipid fluid dispersions comprising ibuprofen: Single step extrusion process and drug properties. International Journal of Pharmaceutics. 2021;598:120289 [Crossref]
244- Wang X, Chen Y, Liu Y, Wu D, Long Y, Gui S, Zheng Z, He N. Nanostructured Lipid Carriers‐Based Topical Gel of Betulinic Acid: In Vitro, In Vivo Evaluation and Dermatokinetic Analysis. Biopharm & Drug Disp. 2025;46(1):10 [Crossref]
245- Izza N, Watanabe N, Okamoto Y, Wibisono Y, Umakoshi H. Characterization of entrapment behavior of polyphenols in nanostructured lipid carriers and its effect on their antioxidative activity. Journal of Bioscience and Bioengineering. 2022;134(3):269 [Crossref]
246- Pavlou P, Siamidi A, Varvaresou A, Vlachou M. Skin Care Formulations and Lipid Carriers as Skin Moisturizing Agents. Cosmetics. 2021;8(3):89 [Crossref]
247- S, Husna N, Rihad R, Utami R. The Incorporation of Clove Essential Oil into Nanostructured Lipid Carrier for Improvement of the Delivery and Antioxidant Effects on the Fibroblast Cells. PNT. 2025;13(2):372 [Crossref]
248- Zafar A, Alruwaili N, Imam S, Alsaidan O, Alharbi K, Yasir M, Elmowafy M, Mohammed E, Al-Oanzi Z. Formulation of Chitosan-Coated Piperine NLCs: Optimization, In Vitro Characterization, and In Vivo Preclinical Assessment. AAPS PharmSciTech. 2021;22(7) [Crossref]
249- Saadh M, Shallan M, Hussein U, Mohammed A, Al-shuwaili S, Shikara M, Ami A, Khalil N, Ahmad I, Abbas H, Elawady A. RETRACTED ARTICLE: Advances in microscopy characterization techniques for lipid nanocarriers in drug delivery: a comprehensive review. Naunyn-Schmiedeberg's Arch Pharmacol. 2024;397(8):5463 [Crossref]
250- Y, Iqubal M, Sartaj A, Khan M, Ali J, Baboota S. Topical delivery of Mannose Conjugated-Doxorubicin-Berberine nanostructured lipid carrier gel for skin cancer amelioration: Formulation optimization, in-silico, in-vitro, ex-vivo assessment, and dermatokinetic analysis. Journal of Drug Delivery Science and Technology. 2024;93:105378 [Crossref]
251- Fitriani E, Avanti C, Rosana Y, Surini S. Nanostructured lipid carriers: A prospective dermal drug delivery system for natural active ingredients. PHAR. 2024;71:1 [Crossref]
252- Hidayat A, Wardhana Y, Suwendar S, Mohammed A, Mahmoud S, Elamin K, Wathoni N. A Review on QbD-Driven Optimization of Lipid Nanoparticles for Oral Drug Delivery: From Framework to Formulation. IJN. 2025;Volume 20:8611 [Crossref]
253- Tran T, Dao T, Nguyen H, Nguyen V, Park J. Application of nanostructured lipid carriers for transdermal drug delivery. J Pharm Investig. 2025; [Crossref]
254- Jiba U, Adil M, Rafiya K, Hasan N, Ahmad F, Amin S. Comprehensive insights into osteoporosis: En-route from conventional therapeutics to nanotechnology-based approaches. Journal of Drug Delivery Science and Technology. 2025;114:107470 [Crossref]
255- Kaur K, Kulkarni Y, Wairkar S. Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems. Brain Research. 2024;1834:148905 [Crossref]
256- Hassan N, Firdaus S, Padhi S, Ali A, Iqbal Z. Investigating natural antibiofilm components: a new therapeutic perspective against candidal vulvovaginitis. Medical Hypotheses. 2021;148:110515 [Crossref]
257- Czajkowska-Kośnik A, Szymańska E, Czarnomysy R, Jacyna J, Markuszewski M, Basa A, Winnicka K. Nanostructured Lipid Carriers Engineered as Topical Delivery of Etodolac: Optimization and Cytotoxicity Studies. Materials. 2021;14(3):596 [Crossref]
258- Patra C, Rout M. Enhancing Bioavailability of Abiraterone Acetate by Nanostructured Lipid Carriers: In Vivo, In Vitro Characterization and Cytotoxicity Assessment. BioNanoSci. 2025;15(4) [Crossref]
259- Jampilek J, Kralova K. Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems. Pharmaceutics. 2022;14(12):2681 [Crossref]
260- Zhang Y, Wu Y, Du H, Li Z, Bai X, Wu Y, Li H, Zhou M, Cao Y, Chen X. Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective. Pharmaceutics. 2023;16(1):7 [Crossref]
261- Agrawal Y, Patil K, More K, Mohd Siddique M, Alkahtani S, Aljarba N, Hasnain M. Amelioration of bioavailability through formulating and optimizing Azilsartan Entrapped nanostructured lipid carriers and its pharmacokinetic assessment. Journal of Drug Delivery Science and Technology. 2022;77:103894 [Crossref]
262- Ardhi A, Raharjo S, Sudjarwo W, Schreiner M. Oxidative stability of optimized nanostructured lipid carriers containing thymoquinone‐rich oil. J Americ Oil Chem Soc. 2025;102(4):793 [Crossref]
263- Narad P, Gokhale K, Wairkar S. Flavonoids-based delivery systems to treat atopic dermatitis. Journal of Drug Delivery Science and Technology. 2024;98:105909 [Crossref]
264- Prakash S. Nano-based drug delivery system for therapeutics: a comprehensive review. Biomed Phys Eng Express. 2023;9(5):052002 [Crossref]
265- V S, Roselin R, Raghavenndra S, M N, A J. Targeting Potential of Zinc Oxide Nanoparticles and Finasteride-loaded Nano Lipidic Carriers-infused Topical Gel - In vitro and In vivo Skin Permeation Studies. Scopus Indexed. 2024;17(1):7210 [Crossref]
266- Zhang W, Meng H, Zhou X, Zhang Z, Zhu G. Effect of solid lipids on the properties of nanostructured lipid carriers: particle size, thermal behavior and crystal structure. J Therm Anal Calorim. 2025;150(19):15583 [Crossref]
267- Kumar M, Kumar D, Mahmood S, Singh V, Chopra S, Hilles A, Bhatia A. Nanotechnology-driven wound healing potential of asiaticoside: a comprehensive review. RSC Pharm. 2024;1(1):9 [Crossref]
268- Carnero Canales C, Marquez Cazorla J, Marquez Cazorla R, Roque-Borda C, Polinário G, Figueroa Banda R, Sábio R, Chorilli M, Santos H, Pavan F. Breaking barriers: The potential of nanosystems in antituberculosis therapy. Bioactive Materials. 2024;39:106 [Crossref]
269- Le T, Le T, Le H, Nguyen T, Le T, Ung T, Tran T, Nguyen V, Nguyen C, Ho H. Preparation, Physicochemical, and Antibacterial Characterization of Nanostructured Lipid Carrier System Containing Tinidazole for Buccal Mucosa Delivery. BioNanoSci. 2025;15(1) [Crossref]
270- Tarek M, El-Gogary R, Kamel A. A new era of psoriasis treatment: Drug repurposing through the lens of nanotechnology and machine learning. International Journal of Pharmaceutics. 2025;673:125385 [Crossref]
271- Alajmi A, Al Otaibi S, Alzubidi A, Alanazi A, Almorshed ‏, Alrbian A. Advancements in nanomedicine: Targeted drug delivery systems for cancer treatment. Int J of Health Sci. 2023;7(S1):3655 [Crossref]
272- Biswas U, Sen S, Sharma S, Paul M, Nayak A, Bose A. Nanostructured Lipid Carrier-based Topical Gels as Novel Drug Delivery System: A Comprehensive Overview. CDD. 2025;22(8):1092 [Crossref]
273- Gangavarapu A, Tapia-Lopez L, Sarkar B, Pena-Zacarias J, Badruddoza A, Nurunnabi M. Lipid nanoparticles for enhancing oral bioavailability. Nanoscale. 2024;16(39):18319 [Crossref]
274- Gangurde S, Aher A, Gujarathi N, Patil T, Aher K. Reformulating rofecoxib: targeted nanostructured lipid carrier gel for localized treatment of rheumatoid arthritis. Drug Development and Industrial Pharmacy. 2026;52(3):537 [Crossref]
275- Matarazzo A, Rios C, Gerônimo G, Ondei R, de Paula E, Breitkreitz M. Development of a Versatile Nanostructured Lipid Carrier (NLC) Using Design of Experiments (DoE)—Part II: Incorporation and Stability of Butamben with Different Surfactants. Pharmaceutics. 2024;16(7):863 [Crossref]
276- Elshazly E, Arafa M, Nour S. Exploration of recent advancements of nanoparticle-based therapeutics emphasis on diabetic-related chronic wound management: a comprehensive review. Arch Pharm Res. 2026;49(1):101 [Crossref]
277- Folle C, Sánchez‑López E, Mallandrich M, Díaz‑Garrido N, Suñer-Carbó J, Halbaut L, Carvajal-Vidal P, Marqués A, Espina M, Badia J, Baldoma L, García M, Calpena A. Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders. International Journal of Pharmaceutics. 2024;651:123732 [Crossref]
278- Petrovici A, Spennato M, Bîtcan I, Péter F, Cotarcă L, Todea A, Ordodi V. A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations. Pharmaceuticals. 2025;18(9):1273 [Crossref]
279- Javia A, Misra A, Thakkar H. Design and pharmacodynamic evaluation of DPK-060 loaded Nanostructured lipid carrier embedded gel for dermal delivery: A novel approach in the treatment of atopic dermatitis. Colloids and Surfaces B: Biointerfaces. 2022;217:112658 [Crossref]
280- Krishnan U. Biomaterials in the treatment of Parkinson's disease. Neurochemistry International. 2021;145:105003 [Crossref]
281- Bodnár K, Fehér P, Ujhelyi Z, Bácskay I, Józsa L. Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles. Pharmaceutics. 2024;16(4):449 [Crossref]
282- Firdous Z, Dhapake P, Padole N, Dhoble N, Baheti J. Different Approaches for Transdermal Nano-Carrier Delivery System. RJTCS. 2023;:94 [Crossref]
283- Rojas J, Cabrera S, Benavides J, Lopera Y, Yarce C. Lipidic Matrixes Containing Clove Essential Oil: Biological Activity, Microstructural and Textural Studies. Molecules. 2021;26(9):2425 [Crossref]
284- Abla K, Hijazi S, Mehanna M. Augmented efficiency of azithromycin for MRSA ocular infections management: Limonene-based nanostructured lipid carriers in-situ approach. Journal of Drug Delivery Science and Technology. 2023;87:104764 [Crossref]
285- Rosita N, Sultani A, Hariyadi D. Penetration study of p-methoxycinnamic acid (PMCA) in nanostructured lipid carrier, solid lipid nanoparticles, and simple cream into the rat skin. Sci Rep. 2022;12(1) [Crossref]
286- Kuwar U, Pradhan M, Dhote N, Patel R, Sinha A, Jain P, Jain A. Novel Approaches and Applications of Nanotechnology in the Delivery of Topical Drugs for Psoriasis via Nanocarriers. CNANO. 2025;21(4):658 [Crossref]
287- Bansal K, Bhati H, Bhati V, Bajpai M. Recent insights into therapeutic potential and nanostructured carrier systems of Centella asiatica: An evidence-based review. Pharmacological Research - Modern Chinese Medicine. 2024;10:100403 [Crossref]
288- Alatawi H, Alhwiti S, Alsharif K, Albalawi S, Abusaleh S, Sror G, Qushawy M. Nanostructured Lipid Carriers (NLCs) as Effective Drug Delivery Systems: Methods of Preparation and their Therapeutic Applications. NANOTEC. 2024;18(2):179 [Crossref]
289- Uti D, Alum E, Atangwho I, Ugwu O, Egbung G, Aja P. Lipid-based nano-carriers for the delivery of anti-obesity natural compounds: advances in targeted delivery and precision therapeutics. J Nanobiotechnol. 2025;23(1) [Crossref]
290- Grewal S, Singh S, Sharma N, Behl T, Grewal I, Gupta S. Insights into the Pivotal Role of Calcium Channel Blockers and Its Nanoformulations in the Management of Hypertension. BioNanoSci. 2023;13(4):1437 [Crossref]
291- Vishwakarma K, Hafeez A, Usmani S, Noor L, Khan I. Nanocarrier-based Delivery Approaches of Mangiferin: An Updated Review on Leveraging Biopharmaceutical Characteristics of the Bioactive. CPB. 2025;26(14):2270 [Crossref]
292- Aslam A, Parveen A, Bano N, Jabeen I, Hassan M, Aftab U, Hareem M, Jubeen F, Shawaf J, Nazir A, Iqbal M. Cocrystallization of 5-FU and novel sulfathiazole Schiff bases: Synthesis, theoretical and experimental anticancer evaluation against MCF-7 and SW-480 cancer cell lines. Journal of Molecular Liquids. 2025;420:126850 [Crossref]
293- Hegde M, Prabhu S, Mutalik S, Chatterjee A, Goda J, Satish Rao B. Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches. J Pharm Investig. 2022;52(1):49 [Crossref]
294- Awadeen R, Boughdady M, Meshali M.

Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles – Formulation and Pharmacodynamic Assessment

. IJN. 2020;Volume 15:8553 [Crossref]
295- Czajkowska-Kośnik A, Szymańska E, Winnicka K. Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study. Molecules. 2022;28(1):235 [Crossref]
296- Abou Assi R, Abdulbaqi I, Siok Yee C. The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. Pharmaceuticals. 2021;14(3):215 [Crossref]
297- Saveleva M, Verkhovskii R, Demina P, Surkov Y, Anisimov R, Prikhozhdenko E, Pidenko P, Serebryakova I, Zaytsev S, Tuchin V, Svenskaya Y. Biodegradable calcium carbonate carriers for the topical delivery of clobetasol propionate. J Mater Chem B. 2024;12(20):4867 [Crossref]
298- Srivastava S, Mathew J, Pandey A. Baicalein—A review on its molecular mechanism against breast cancer and delivery strategies. Med Chem Res. 2023;32(4):643 [Crossref]
299- Martins M, Veiga F, Paiva-Santos A, Pires P. Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects. ACS Pharmacol Transl Sci. 2025;8(2):308 [Crossref]
300- Jan N, Shah H, Khan S, Nasar F, Madni A, Badshah S, Ali A, Bostanudin M. Old drug, new tricks: polymer-based nanoscale systems for effective cytarabine delivery. Naunyn-Schmiedeberg's Arch Pharmacol. 2024;397(6):3565 [Crossref]
301- Rajpoot K, Prajapati S, Malaiya A, Jain R, Jain A. Meropenem-Loaded Nanostructured Lipid Carriers For Skin and Soft Tissue Infection Caused by Staphylococcus aureus: Formulation, Design, and Evaluation. AAPS PharmSciTech. 2022;23(7) [Crossref]
302- Zahoor I, Singh S, Sharma N, Wani S, Kishore L. Potential role of nanostructured lipid carrier as cutting-edge approach for drug delivery of nonsteroidal anti-inflammatory drugs. Scripta Medica. 2025;56(6):521 [Crossref]
303- Sahoo L, Jena G, Patro C. Impact of Parameter on Nanostructured Lipid Carrier Formulation and Approach of the Carrier for Cancer Treatment: a Brief Study. Razrabotka i registraciâ lekarstvennyh sredstv. 2022;11(4):95 [Crossref]
304- Nayak P, Jose J, Gopan G, Bandiwadekar A, Khot K, I K C, Iravattur S. Anti-obesity effect of resveratrol-loaded dissolving microneedle patch: In vitro and in vivo studies. Materials Today Communications. 2024;41:111011 [Crossref]
305- Giri P, Banerjee A, Layek B. A Recent Review on Cancer Nanomedicine. Cancers. 2023;15(8):2256 [Crossref]
306- Dlamini S, Omolo C, Elhassan E, Ismail E, Peters X, Kassam S, Gafar M, Govender J, Chemonges C, Govender T. Enhancing activity and overcoming ciprofloxacin resistance via multifunctional nanostructured lipid carriers. Journal of Drug Delivery Science and Technology. 2025;108:106933 [Crossref]
307- N. Synthesis and Cytotoxicity Assessment of Curcumin-Derived Nickel Chloride Nanoparticles for ID8 mouse ovarian epithelial cancer cells. Aca Intl J V Med. 2025;:09 [Crossref]
308- Palaria B, Tiwari V, Tiwari A, Aslam R, Kumar A, Sahoo B, Kumar M, Singh S, Kumar S. Nanostructured Lipid Carriers: A Promising Carrier in Targeted Drug Delivery System. CNM. 2023;8(1):23 [Crossref]
309- Jahan S, Aqil M, Ahad A, Imam S, Waheed A, Qadir A, Ali A. Nanostructured lipid carrier for transdermal gliclazide delivery: development and optimization by Box-Behnken design. Inorganic and Nano-Metal Chemistry. 2024;54(5):474 [Crossref]
310- Tanyapanyachon P, Dana P, Thumsongsiri N, Chonniyom W, Saengkrit N. Interrupting the blood-testis barrier with a flutamide-loaded nanostructured lipid carrier: A novel nonsurgical contraceptive approach for male animals. Theriogenology. 2023;206:96 [Crossref]
311- Abdol Wahab N, Meor Mohd Affandi M, Fakurazi S, Alias E, Hassan H. Nanocarrier System: State-of-the-Art in Oral Delivery of Astaxanthin. Antioxidants. 2022;11(9):1676 [Crossref]
312- Das M, Sarma A, Baruah H, Basak D. Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway. RSC Pharm. 2024;1(5):904 [Crossref]
313- Venturini J, Chakraborty A, Baysal M, Tsimberidou A. Developments in nanotechnology approaches for the treatment of solid tumors. Exp Hematol Oncol. 2025;14(1) [Crossref]
314- Pitterou I, Kostopoulou I, Karadendrou M, Mitsioni M, Fountzoula C, Kriebardis A, Miliaronikolaki M, Paraskevopoulos N, Tzani A, Detsi A. Chitosan-Coated Nanostructured Lipid Carriers (NLCs) Incorporating Esters of Ferulic Acid with Photoprotective Activity. Macromol. 2025;5(4):50 [Crossref]
315- Carnero Canales C, Roque‐Borda C, Cazorla J, Cazorla R, Apaza U, Silva V, Primo L, Martínez‐Morales M, Miguel Sábio R, Santos H, Pavan F. Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens. Small. 2025;21(26) [Crossref]
316- Priya S, Desai V, Singh H, Taliyan R, Singhvi G. Enhancing 3-acetyl-11-keto-β-boswellic acid skin permeation via nanostructured lipid carriers: integrating quality by design principles for risk estimation and optimization. Nanoscale Adv. 2025;7(22):7285 [Crossref]
317- Hafez Ghoran S, Calcaterra A, Abbasi M, Taktaz F, Nieselt K, Babaei E. Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment. Molecules. 2022;27(16):5236 [Crossref]
318- Mehanna M, Abla K, Domiati S, Elmaradny H. Superiority of microemulsion-based hydrogel for non-steroidal anti-inflammatory drug transdermal delivery: a comparative safety and anti-nociceptive efficacy study. International Journal of Pharmaceutics. 2022;622:121830 [Crossref]
319- Junqueira L, Polonini H, Ramos C, Ferreira A, Raposo N, Brandão M. Assessment of a Novel Vitamin D3 Formulation with Nanostructured Lipid Carriers for Transdermal Delivery. CDD. 2022;19(5):614 [Crossref]
320- Biswas B, Bandyopadhyay T, Bhowmick T. Functionalization of Polymeric Nanocarriers with Anti-tubercular Drug (isoniazid) for Cell-specific Targeting. BioNanoSci. 2025;15(4) [Crossref]
321- Han W, Liu F, Li Y, Liu G, Li H, Xu Y, Sun S. Advances in Natural Polymer‐Based Transdermal Drug Delivery Systems for Tumor Therapy. Small. 2023;19(35) [Crossref]
322- Hafez D, Hassanin I, Teleb M, Khattab S, Elkhodairy K, Elzoghby A. Recent Advances in Nanomedicine-Based Delivery of Histone Deacetylase Inhibitors for Cancer Therapy. Nanomedicine (Lond). 2021;16(25):2305 [Crossref]
323- Kamal N, Heikal L, Helmy M, Abdallah O. Bromelain-functionalized omega-3 nanocarriers for targeted icariin delivery: a multifunctional shield for cardiac repair in doxorubicin-induced injury. J Mater Sci: Mater Med. 2025;36(1) [Crossref]
324- Kataria D, Zafar A, Ali J, Khatoon K, Khan S, Imam S, Yasir M, Ali A. Formulation of Lipid-Based Nanocarriers of Lacidipine for Improvement of Oral Delivery: Box-Behnken Design Optimization, In Vitro, Ex Vivo, and Preclinical Assessment. ASSAY and Drug Development Technologies. 2022;20(1):5 [Crossref]
325- Ghanem H, Nasr A, Hassan T, Elkhoudary M, Alshaman R, Alattar A, Gad S. Comprehensive Study of Atorvastatin Nanostructured Lipid Carriers through Multivariate Conceptualization and Optimization. Pharmaceutics. 2021;13(2):178 [Crossref]
326- Rajput A, Pingale P, Telange D, Chalikwar S, Borse V. Lymphatic transport system to circumvent hepatic metabolism for oral delivery of lipid-based nanocarriers. Journal of Drug Delivery Science and Technology. 2021;66:102934 [Crossref]
327- Alwani S, Wasan E, Badea I. Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery Applications. Mol Pharmaceutics. 2024;21(7):3084 [Crossref]
328- Suthar R, Yadav R, Kumari P, Mehra N. Nanotechnology in gynaecological cancers: Biomedical perspectives on lipid-based drug delivery systems for targeted therapy. International Journal of Pharmaceutics. 2026;687:126402 [Crossref]
329- Sulthana A, Raguvaran K, Prabu P, Mani R, Sundaramoorthi C, Padarthi P, Ragavendran C, Manimegalai T, Elangovan N. Design, preparation, and in vitro characterizations of chitosan-loaded nanostructured lipid carriers: a promising drug delivery system. Biomass Conv Bioref. 2024;14(20):26459 [Crossref]
330- Salgaonkar S, Purewal J, Doshi G, Fernandes T, Gharat S, Sawarkar S. New Insights in Psoriasis Management using Herbal Drug Nanocarriers. CPD. 2024;30(32):2550 [Crossref]
331- Nirmal P, Singh N, Singh R. Challenges and Opportunities in the Development of Nano-Structured Lipid Carriers for Brain Targeting. ijnrph. 2025;:87 [Crossref]
332- Jain A, Yadav S, Khan J. Revolutionizing Wound Healing: Unleashing Nanostructured Lipid Carriers Embodied with Herbal Medicinal Plant. CPB. 2025;26(8):1159 [Crossref]
333- Hassan D, El-Kamel A, Allam E, Bakr B, Ashour A. Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson’s disease: interplay between nuclear factor-kappa β and cathepsin B. Drug Deliv and Transl Res. 2024;14(2):400 [Crossref]
334- Bhatia M, Kumar S, Kapoor A, Lohan S. A Review on the Drug Delivery Strategies for Parasitic Infections: Scope and Assertion. DDL. 2022;12(2):109 [Crossref]
335- Su X, Zhong H, Zeng Y, Zhang Y, Zhang B, Guo W, Huang Q, Ye Y. Dual-ligand-functionalized nanostructured lipid carriers as a novel dehydrocavidine delivery system for liver fibrosis therapy. Colloids and Surfaces B: Biointerfaces. 2025;246:114376 [Crossref]
336- Ou L, Setegne M, Elliot J, Shen F, Dassama L. Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. Chem Rev. 2025;125(4):2120 [Crossref]
337- Boff J, Reis A, de Oliveira J, Gross R, Fraceto L, Melo A, Bernardi O. Development and biological evaluation of nanoencapsulated‐based pyrethroids with synergists for resistance management of two soybean pests: insights for new insecticide formulations. Pest Management Science. 2023;79(3):1204 [Crossref]
338- Stefanova D, Yordanov Y, Bogdanova R, Voycheva C, Tzankov B, Popova T, Kondeva-Burdina M, Tzankova V, Toncheva-Moncheva N, Tzankova D, Slavkova M. In Vitro Evaluation of the Safety and Antineoplastic Effects in Gastrointestinal Tumors of Nanostructured Lipid Carriers Loaded with Berberine. Pharmaceutics. 2025;17(3):331 [Crossref]
339- Logesh K, Raj B, Bhaskaran M, Thirumaleshwar S, Gangadharappa H, Osmani R, Asha Spandana K. Nanoparticulate drug delivery systems for the treatment of rheumatoid arthritis: A comprehensive review. Journal of Drug Delivery Science and Technology. 2023;81:104241 [Crossref]
340- Singh A, Kumar M, Upadhyay P. Methods for the Encapsulation of Hydrophilic Drugs in Lipid-Based Nanocarriers, Solid Lipid Nanoparticles, and Nanostructured Lipid Carriers: A Short Review and Perspective. CNANOM. 2025;15(4):448 [Crossref]
341- Ahalwat S, Bhatt D, Rohilla S. Fabrication of Lipid Combination for Bioavailability Enhancement of Isoniazid. RJPT. 2022;:5589 [Crossref]
342- Motsoene F, Abrahamse H, Dhilip Kumar S. Multifunctional lipid-based nanoparticles for wound healing and antibacterial applications: A review. Advances in Colloid and Interface Science. 2023;321:103002 [Crossref]
343- Keyvani V, Mollazadeh S, Riahi E, Mahmoudian R, Tabari M, Lagzian E, Ghorbani E, Akbarzade H, Gholami A, Gataa I, Hassanian S, Ferns G, Khazaei M, Avan A, Anvari K. The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers. CPD. 2024;30(13):975 [Crossref]
344- Bharti S, Sharma G, Sarwal A, Katare O. Nano Lipid Carriers (NLCs): Potential and Promises in Drug Delivery . Crit Rev Ther Drug Carrier Syst. 2026;43(1):97 [Crossref]
345- Wu K, Joly-Chevrier M, Akbar D, Tran S. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems. Pharmaceutics. 2023;15(4):1094 [Crossref]
346- Qiu C, Zhang J, Wu B, Xu C, Pang H, Tu Q, Lu Y, Guo Q, Xia F, Wang J. Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines. J Nanobiotechnol. 2023;21(1) [Crossref]
347- Pandey A, Rath G, Chawala R, Goyal A. A comprehensive review on liraglutide and novel nanocarrier-based systems for the effective delivery of liraglutide. Naunyn-Schmiedeberg's Arch Pharmacol. 2025;398(7):8241 [Crossref]
348- Moazeni M, Kelidari H, Nasirzadehfard Y, Shokohi T, Roohi B, Hajheidari Z, Kazeminejad A, Parsay S, Asare-Addo K, Nokhodchi A. Lesson from nature: Zataria multiflora nanostructured lipid carrier topical gel formulation against Candida-associated onychomycosis, a randomized double-blind placebo-controlled clinical trial. Medicine in Drug Discovery. 2024;22:100187 [Crossref]
349- Lin C, Lin Z, Chang Y, Lin T, Fang J. Novel strategies in topical delivery for psoriasis treatment: nanocarriers and energy-driven approaches. Expert Opinion on Drug Delivery. 2025;22(4):565 [Crossref]
350- Gunawan M, Bestari A, Ramadon D, Efendi A, Boonkanokwong V. Combination of lipid-based nanoparticles with microneedles as a promising strategy for enhanced transdermal delivery systems: A comprehensive review. Journal of Drug Delivery Science and Technology. 2025;107:106807 [Crossref]
351- Cassano R, Furia E, Trombino S, Elliani R, Borgia C, Gagliardi F, Curcio F. Nanoformulations of Cosmetic Interest for the Cutaneous Uptake of Nickel. Inorganics. 2025;13(3):78 [Crossref]
352- Khan M, Mohapatra S, Gupta V, Ali A, Naseef P, Kurunian M, Alshadidi A, Alam M, Mirza M, Iqbal Z. Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier. Membranes. 2023;13(3):343 [Crossref]
353- Zulfakar M, Pubadi H, Ibrahim S, Hairul N. Medium-Chain Triacylglycerols (MCTs) and Their Fractions in Drug Delivery Systems : A Systematic Review. J Oleo Sci. 2024;73(3):293 [Crossref]
354- Singh T, Arora A, Sahu K, Patel P, Kaur S, Thakur S, Gupta G, Singh D, Kurmi B. A complete sojourn of recent advancements and applications in transdermal drug delivery systems. Journal of Drug Delivery Science and Technology. 2024;102:106328 [Crossref]
355- Shadrack S, Wang Y, Mi S, Lu R, Zhu Y, Tang Z, McClements D, Cao C, Xu X, Li W, Yuan B. Enhancing bioavailability and functionality of plant peptides and proteins: A review of novel strategies for food and pharmaceutical applications. Food Chemistry. 2025;485:144440 [Crossref]
356- Saini S, Dagar P, Gupta S, Kumar Y. A nanotherapeutic approach for fighting the odds against the malignant disorders. J Nanopart Res. 2023;25(6) [Crossref]
357- Chavda V, Acharya D, Hala V, Daware S, Vora L. Sunscreens: A comprehensive review with the application of nanotechnology. Journal of Drug Delivery Science and Technology. 2023;86:104720 [Crossref]
358- Wilie Y, Gunawan M, Hadad Y, Ramadon D, Saputri F, Jansook P, Boonkanokwong V, Iswandana R. Revolutionizing colon-targeted drug delivery: The pivotal role of lipid nano-carriers and their transformative modifications. Journal of Drug Delivery Science and Technology. 2025;113:107319 [Crossref]
359- Marlina A, Misran M, Ndruru S, Annas D, Septiyani M, Sampora Y, Mawarni R. Pea Protein Isolate—Enhanced Nanostructured Lipid Carriers with Beeswax for Limonene Encapsulation: Exploring Physicochemical Properties and In Vitro Insights. ChemistrySelect. 2025;10(41) [Crossref]
360- Tyagi B, Verma M. Nano Lipid Carriers: A Novel Approach for Nose to Brain Drug Delivery. CIS. 2024;02 [Crossref]
361- Saha A, Chauhan S, Singh I. Targeted Drug Delivery with Lipid-based Nanoparticles: Innovations for Improved Cancer Therapy. NANOASIA. 2024;14(5) [Crossref]
362- Xing H, Pan X, Hu Y, Yang Y, Zhao Z, Peng H, Wang J, Li S, Hu Y, Li G, Ma D. High molecular weight hyaluronic acid-liposome delivery system for efficient transdermal treatment of acute and chronic skin photodamage. Acta Biomaterialia. 2024;182:171 [Crossref]
363- Ghosh D, Guin A, Kumar A, Das A, Paul S. Comprehensive insights of etiological drivers of hepatocellular carcinoma: Fostering targeted nano delivery to anti-cancer regimes. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(3):189318 [Crossref]
364- Lokman Hakim N, Joginder Singh H, Kang Nien H, Siau Hui M, Zee Wei L. Kojic Acid and Kojic Acid Ester: Review on Nanotechnology-based Approach for Enhancing the Delivery Efficacy. RADDF. 2023;17(2):90 [Crossref]
365- Adianingsih O, Latifani S, Fitriani A, Wardani A, Qurrotuain I, Wahyudi R, Dewi A, Dhinata J, Rumabutar G, Puspita O, Ihsan B, Riawan W, Danimayostu A, Yurina V. Anti-aging evaluation of transfersome and nanostructured lipid carrier gels containing Curcuma longa and Glycyrrhiza glabra extract on ultraviolet-B-irradiated rats. PHAR. 2025;72:1 [Crossref]
366- El-Dakroury W, Nomier Y, Said A, Taura M, Soliman Doghish A, Shalaby A, Sarhan O. Evaluation of Chitosan–Pimelate Buccal Film Loaded with Duloxetine-Modified Sage Lipid Carriers Nanoformulation for Effective Antidepressant Activity in a Rat Model. IJN. 2026;Volume 21:1 [Crossref]
367- Ehrensberger C. Vakzine: Gut umhüllt zum Ziel. Nachr Chem. 2021;69(11):41 [Crossref]
368- Kumar H, Chand P, Pachal S, Mallick S, Jain R, Madhunapantula S, Jain V. Fisetin-Loaded Nanostructured Lipid Carriers: Formulation and Evaluations against Advanced and Metastatic Melanoma. Mol Pharmaceutics. 2023;20(12):6035 [Crossref]
369- Okuyucu C, Kalaycioglu G, Kacaroglu D, Ozden A, Aydogan N. Trojan-like doxorubicin and gold nanoparticle entrapped smart nanostructured lipid carriers for breast cancer synergistic chemo/photothermal therapy. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2023;672:131763 [Crossref]
370- Souto E, Jäger E, Jäger A, Štěpánek P, Cano A, Viseras C, de Melo Barbosa R, Chorilli M, Zielińska A, Severino P, Naveros B. Lipid Nanomaterials for Targeted Delivery of Dermocosmetic Ingredients: Advances in Photoprotection and Skin Anti-Aging. Nanomaterials. 2022;12(3):377 [Crossref]
371- Soliman B, Wen M, Kandil E, El-Agamy B, Gamal-Eldeen A, ElHefnawi M. Preparation and Optimization of MiR-375 Nano-Vector Using Two Novel Chitosan-Coated Nano-Structured Lipid Carriers as Gene Therapy for Hepatocellular Carcinoma. Pharmaceutics. 2024;16(4):494 [Crossref]
372- Rimsueb N, Tabboon P, Bunwatcharaphansakun P, Ruktanonchai U, Namdee K, Asawapirom U, Sripanidkulchai B, Tuntiyasawasdikul S, Somintara S, Rudtanatip T, Khongkow M. Oral delivery of Kaempferia parviflora's methoxyflavones via nanostructured lipid carriers: Its effect on obesity and dyslipidemia treatment”. International Journal of Pharmaceutics: X. 2025;9:100345 [Crossref]
373- Rani D, Sharma V, Chauhan B, Singh R. RECENT ADVANCES IN NANOTECHNOLOGY - BASED DRUG DELIVERY SYSTEMS FOR DELIVERY OF PHYTOCONSTITUENTS WITH SPECIAL EMPHASIS ON PSORIASIS MANAGEMENT. IND DRU. 2024;61(04):7 [Crossref]
374- Behar L, Siddique H. Antioxidant Delivery Revisited: The Promise of Nanostructured Lipid Carriers. Medicines. 2026;13(1):2 [Crossref]
375- Geng Q, Zhao Y, Wang L, Xu L, Chen X, Han J. Development and Evaluation of Astaxanthin as Nanostructure Lipid Carriers in Topical Delivery. AAPS PharmSciTech. 2020;21(8) [Crossref]